Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Dec;70(6):1205–1215. doi: 10.1172/JCI110719

Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens.

C L Berger, S Morrison, A Chu, J Patterson, A Estabrook, S Takezaki, J Sharon, D Warburton, O Irigoyen, R L Edelson
PMCID: PMC370337  PMID: 6217214

Abstract

Two murine monoclonal antibodies (BE1 and BE2), produced by using leukemic helper T cells from a patient with cutaneous T-cell lymphoma (CTCL) as immunogens, reacted selectively with CTCL lymphocytes and some transformed cultured lymphocytes, as determined by radioimmunoassay (RIA) and indirect immunofluorescence (IIF). BE1 reacted significantly (P less than or equal to 0.001) with leukemic CTCL lymphocytes and with CTCL cells from infiltrated lymph nodes (RIA, mean +/- SD = 776 +/- 275 cpm), as compared with background counts (263 +/- 68). BE1 binding to normal blood mononuclear cells (RIA, mean +/- SD = 283 +/- 58 cpm) was indistinguishable from background. BE1 also reacted with Epstein-Barr virus (EBV)-transformed B-cell lines (RIA, mean +/- SD = 794 +/- 230) and some long-term T-cell lines. BE1 did not react with the majority of lymphoid cell lines or tumor cell lines tested. BE1 also did not react with any normal tissues screened by IIF. BE1 precipitated a molecule from CTCL cells that, under reducing conditions, has two components with molecular mass of 27,200 and 25,800 D. BE2 also reacted significantly (P less than or equal to 0.001) with CTCL cells from two of four patients (RIA, mean +/- SD = 519 +/- 113 cpm). The binding of BE2 to normal mononuclear cells was indistinguishable from background (309 +/- 38 cpm). BE2 also reacted with an antigen present on EBV-B-cell lines (RIA, mean +/- SD = 654 +/- 194) and MOLT 3 and HUT 78 T-cell lines. BE2 reacted with an antigen expressed on a subpopulation of lymphocytes from five of eight patients with B-cell CLL studied by IIF (mean +/- SD = 18 +/- 6). Other long-term T-cell lines and tumor cell lines studied by IIF were unreactive with BE2. BE2 did not react with any of the normal tissues studied. BE2 precipitated a molecule (78,000 D) from CTCL cells and EBV-B cells with a single component under reducing conditions. Immunoperoxidase-labeled BE1 and BE2 reacted with CTCL cells in frozen sections of infiltrated lymph nodes and skin. In addition, BE1 and BE2 reacted with blood lymphocytes from 16 of 21 patients whose CTCL had otherwise been considered localized to skin. These two monoclonal antibodies react with tumor antigens associated with CTCL and appear to be useful in the diagnosis of this disorder.

Full text

PDF
1205

Images in this article

1210Image
on p.1210
1214Image
on p.1214

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger C. L., Warburton D., Raafat J., LoGerfo P., Edelson R. L. Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity. Blood. 1979 Apr;53(4):642–651. [PubMed] [Google Scholar]
  2. Boumsell L., Bernard A., Reinherz E. L., Nadler L. M., Ritz J., Coppin H., Richard Y., Dubertret L., Valensi F., Degos L. Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells. Blood. 1981 Mar;57(3):526–530. [PubMed] [Google Scholar]
  3. Braylan R., Variakojis D., Yachnin S. The Sézary syndrome lymphoid cell: abnormal surface properties and mitogen responsiveness. Br J Haematol. 1975 Dec;31(4):553–564. doi: 10.1111/j.1365-2141.1975.tb00890.x. [DOI] [PubMed] [Google Scholar]
  4. Broder S., Edelson R. L., Lutzner M. A., Nelson D. L., MacDermott R. P., Durm M. E., Goldman C. K., Meade B. D., Waldmann T. A. The Sézary syndrome: a malignant proliferation of helper T cells. J Clin Invest. 1976 Dec;58(6):1297–1306. doi: 10.1172/JCI108585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown G., Hogg N., Greaves M. Candidate leukaemia-specific antigen in man. Nature. 1975 Dec 4;258(5534):454–456. doi: 10.1038/258454a0. [DOI] [PubMed] [Google Scholar]
  6. Bunn P. A., Jr, Huberman M. S., Whang-Peng J., Schechter G. P., Guccion J. G., Matthews M. J., Gazdar A. F., Dunnick N. R., Fischmann A. B., Ihde D. C. Prospective staging evaluation of patients with cutaneous T-cell lymphomas. Demonstration of a high frequency of extracutaneous dissemination. Ann Intern Med. 1980 Aug;93(2):223–230. doi: 10.7326/0003-4819-93-2-223. [DOI] [PubMed] [Google Scholar]
  7. Böyum A. Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents. Scand J Clin Lab Invest Suppl. 1968;97:31–50. [PubMed] [Google Scholar]
  8. Chu A. C., MacDonald D. M. Identification in situ of T lymphocytes in the dermal and epidermal infiltrates of mycosis fungoides. Br J Dermatol. 1979 Feb;100(2):177–182. doi: 10.1111/j.1365-2133.1979.tb05558.x. [DOI] [PubMed] [Google Scholar]
  9. Colcher D., Hand P. H., Nuti M., Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A. 1981 May;78(5):3199–3203. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Edelson R. L., Berger C. L., Raafat J., Warburton D. Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. J Invest Dermatol. 1979 Dec;73(6):548–550. doi: 10.1111/1523-1747.ep12541543. [DOI] [PubMed] [Google Scholar]
  11. Edelson R. L. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol. 1980 Feb;2(2):89–106. doi: 10.1016/s0190-9622(80)80385-9. [DOI] [PubMed] [Google Scholar]
  12. Edelson R. L. Cutaneous T-cell lymphoma. J Dermatol Surg Oncol. 1980 May;6(5):358–368. doi: 10.1111/j.1524-4725.1980.tb00880.x. [DOI] [PubMed] [Google Scholar]
  13. Edelson R. L., Raafat J., Berger C. L., Grossman M., Troyer C., Hardy M. Antithymocyte globulin in the management of cutaneous T cell lymphoma. Cancer Treat Rep. 1979 Apr;63(4):675–680. [PubMed] [Google Scholar]
  14. Epstein E. H., Jr, Levin D. L., Croft J. D., Jr, Lutzner M. A. Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings. Medicine (Baltimore) 1972 Jan;51(1):61–72. [PubMed] [Google Scholar]
  15. Haynes B. F., Metzgar R. S., Minna J. D., Bunn P. A. Phenotypic characterization of cutaneous T-cell lymphoma. Use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med. 1981 May 28;304(22):1319–1323. doi: 10.1056/NEJM198105283042202. [DOI] [PubMed] [Google Scholar]
  16. Imai K., Molinaro G. A., Ferrone S. Monoclonal antibodies to human melanoma-associated antigens. Transplant Proc. 1980 Sep;12(3):380–383. [PubMed] [Google Scholar]
  17. Kung P. C., Berger C. L., Goldstein G., LoGerfo P., Edelson R. L. Cutaneous T cell lymphoma: characterization by monoclonal antibodies. Blood. 1981 Feb;57(2):261–266. [PubMed] [Google Scholar]
  18. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  19. Magnani J. L., Brockhaus M., Smith D. F., Ginsburg V., Blaszczyk M., Mitchell K. F., Steplewski Z., Koprowski H. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science. 1981 Apr 3;212(4490):55–56. doi: 10.1126/science.7209516. [DOI] [PubMed] [Google Scholar]
  20. Marchalonis J. J., Cone R. E., Santer V. Enzymic iodination. A probe for accessible surface proteins of normal and neoplastic lymphocytes. Biochem J. 1971 Oct;124(5):921–927. doi: 10.1042/bj1240921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Meyer C. J., van Leeuwen A. W., van der Loo E. M., van de Putte L. B., van Vloten W. A. Cerebriform (Sézary like) mononuclear cells in healthy individuals: a morphologically distinct population of T cells. Relationship with mycosis fungoides and Sézary's syndrome. Virchows Arch B Cell Pathol. 1977 Oct 27;25(2):95–104. doi: 10.1007/BF02889424. [DOI] [PubMed] [Google Scholar]
  22. Miller R. A., Levy R. Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet. 1981 Aug 1;2(8240):226–230. doi: 10.1016/s0140-6736(81)90475-x. [DOI] [PubMed] [Google Scholar]
  23. Miller R. A., Maloney D. G., McKillop J., Levy R. In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood. 1981 Jul;58(1):78–86. [PubMed] [Google Scholar]
  24. Miller R. A., Maloney D. G., Warnke R., Levy R. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med. 1982 Mar 4;306(9):517–522. doi: 10.1056/NEJM198203043060906. [DOI] [PubMed] [Google Scholar]
  25. Mohanakumar T., Metzgar R. S., Miller D. S. Human leukemia cell antigens: serologic characterization with xenoantisera. J Natl Cancer Inst. 1974 May;52(5):1435–1444. doi: 10.1093/jnci/52.5.1435. [DOI] [PubMed] [Google Scholar]
  26. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ritz J., Pesando J. M., Notis-McConarty J., Lazarus H., Schlossman S. F. A monoclonal antibody to human acute lymphoblastic leukaemia antigen. Nature. 1980 Feb 7;283(5747):583–585. doi: 10.1038/283583a0. [DOI] [PubMed] [Google Scholar]
  28. Schechter G. P., Bunn P. A., Fischmann A. B., Matthews M. J., Guccion J., Soehnlen F., Munson D., Minna J. D. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy. Cancer Treat Rep. 1979 Apr;63(4):571–574. [PubMed] [Google Scholar]
  29. Sharon J., Morrison S. L., Kabat E. A. Formation of hybridoma clones in soft agarose: effect of pH and of medium. Somatic Cell Genet. 1980 May;6(3):435–441. doi: 10.1007/BF01542794. [DOI] [PubMed] [Google Scholar]
  30. Weiner M. S., Bianco C., Nussenzweig V. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes. Blood. 1973 Dec;42(6):939–946. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES